Nasal congestion with iloperidone therapy in a case series
1, 2, 3,4★, 5★ Corresponding author
- 1Nalmuri Block Primary Health Centre, West Bengal 743 502, INDIA.
- 2Department of Psychiatry, Medical College, Kolkata 700 073, INDIA.
- 3Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad 201 002, INDIA.
- 4Department of Clinical and Experimental Pharmacology, Calcutta School of Tropical Medicine, Kolkata 700 073, INDIA.
- 5Department of Community Medicine, Burdwan Medical College and Hospital, West Bengal 713 104, INDIA.
CORRESPONDENCE
Somnath Mondal
Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad 201 002, INDIA.
Received: 30-06-2013; Revised: 05-07-2013; Accepted: 07-09-2013.
Volume 5, Issue 3 · pp. 108-109 · 2013 · DOI: 10.1016/j.jyp.2013.08.003
ABSTRACT
Iloperidone or 40-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino] propoxy]-30-methoxyacetophenone is an atypical psychotropic agent belonging to piperidinyl-benzisoxazole derivative, having marked antagonistic actions on adrenergic, serotonergic, and dopaminergic receptors. It is an excellent emerging drug in anxiety and schizophrenia, and particularly useful in acute stages due to involvement of single nucleotide polymorphism in action.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Das, S., Saha, I., Mondal, S., & Bandyopadhyay, S. (2013). Nasal congestion with iloperidone therapy in a case series. Journal of Young Pharmacists, 5(3), 108-109. https://doi.org/10.1016/j.jyp.2013.08.003
Copyright and licence
© 2013 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0